Senzime AB (SEZI) - Total Liabilities

Latest as of March 2026: Skr66.51 Million SEK ≈ $7.16 Million USD

Based on the latest financial reports, Senzime AB (SEZI) has total liabilities worth Skr66.51 Million SEK (≈ $7.16 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Senzime AB - Total Liabilities Trend (2005–2025)

This chart illustrates how Senzime AB's total liabilities have evolved over time, based on quarterly financial data. See Senzime AB short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Senzime AB Competitors by Total Liabilities

The table below lists competitors of Senzime AB ranked by their total liabilities.

Company Country Total Liabilities
AGROB Immobilien AG
F:AGR
Germany €117.93 Million
e-LITECOM CO. Ltd
KQ:041520
Korea ₩10.24 Billion
SRV Group plc
HE:SRV1V
Finland €377.80 Million
Vakrangee Limited
NSE:VAKRANGEE
India Rs1.25 Billion
Cintac
SN:CINTAC
Chile CL$448.56 Million
Shanghai Shibei Hi-Tech Co Ltd B
SHG:900902
China $12.13 Billion
Siebert Financial Corp
NASDAQ:SIEB
USA $509.02 Million

Liability Composition Analysis (2005–2025)

This chart breaks down Senzime AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Senzime AB market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.76 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.23 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.19 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Senzime AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Senzime AB (2005–2025)

The table below shows the annual total liabilities of Senzime AB from 2005 to 2025.

Year Total Liabilities Change
2025-12-31 Skr65.35 Million
≈ $7.03 Million
-16.94%
2024-12-31 Skr78.67 Million
≈ $8.47 Million
+35.49%
2023-12-31 Skr58.06 Million
≈ $6.25 Million
-4.46%
2022-12-31 Skr60.78 Million
≈ $6.54 Million
+152.80%
2021-12-31 Skr24.04 Million
≈ $2.59 Million
-12.72%
2020-12-31 Skr27.55 Million
≈ $2.96 Million
+14.45%
2019-12-31 Skr24.07 Million
≈ $2.59 Million
-19.10%
2018-12-31 Skr29.75 Million
≈ $3.20 Million
+16.33%
2017-12-31 Skr25.57 Million
≈ $2.75 Million
+4.63%
2016-12-31 Skr24.44 Million
≈ $2.63 Million
+1126.44%
2015-12-31 Skr1.99 Million
≈ $214.46K
-10.94%
2014-12-31 Skr2.24 Million
≈ $240.79K
+91.47%
2013-12-31 Skr1.17 Million
≈ $125.76K
-6.29%
2012-12-31 Skr1.25 Million
≈ $134.19K
-67.12%
2011-12-31 Skr3.79 Million
≈ $408.17K
-5.82%
2010-12-31 Skr4.03 Million
≈ $433.39K
-11.76%
2009-12-31 Skr4.56 Million
≈ $491.13K
-5.42%
2008-12-31 Skr4.83 Million
≈ $519.27K
+11.44%
2007-12-31 Skr4.33 Million
≈ $465.98K
+34.39%
2006-12-31 Skr3.22 Million
≈ $346.74K
+7.22%
2005-12-31 Skr3.00 Million
≈ $323.39K
--

About Senzime AB

ST:SEZI Sweden Medical Devices
Market Cap
$74.61 Million
Skr693.32 Million SEK
Market Cap Rank
#20433 Global
#367 in Sweden
Share Price
Skr4.41
Change (1 day)
-1.45%
52-Week Range
Skr4.10 - Skr7.27
All Time High
Skr26.50
About

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impeda… Read more